Mastrangelo D - Search Results

1

Aberrant methylation of the HIC1 promoter is a frequent event in specific pediatric neoplasms.

Rathi A, Virmani AK, Harada K, Timmons CF, Miyajima K, Hay RJ, Mastrangelo D, Maitra A, Tomlinson GE, Gazdar AF. Rathi A, et al. Among authors: mastrangelo d. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3674-8. Clin Cancer Res. 2003. PMID: 14506157

2

Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines.

Harada K, Toyooka S, Maitra A, Maruyama R, Toyooka KO, Timmons CF, Tomlinson GE, Mastrangelo D, Hay RJ, Minna JD, Gazdar AF. Harada K, et al. Among authors: mastrangelo d. Oncogene. 2002 Jun 20;21(27):4345-9. doi: 10.1038/sj.onc.1205446. Oncogene. 2002. PMID: 12082624

3

Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines.

Harada K, Toyooka S, Shivapurkar N, Maitra A, Reddy JL, Matta H, Miyajima K, Timmons CF, Tomlinson GE, Mastrangelo D, Hay RJ, Chaudhary PM, Gazdar AF. Harada K, et al. Among authors: mastrangelo d. Cancer Res. 2002 Oct 15;62(20):5897-901. Cancer Res. 2002. PMID: 12384554

4

Aberrant methylation of HIN-1 (high in normal-1) is a frequent event in many human malignancies.

Shigematsu H, Suzuki M, Takahashi T, Miyajima K, Toyooka S, Shivapurkar N, Tomlinson GE, Mastrangelo D, Pass HI, Brambilla E, Sathyanarayana UG, Czerniak B, Fujisawa T, Shimizu N, Gazdar AF. Shigematsu H, et al. Among authors: mastrangelo d. Int J Cancer. 2005 Feb 10;113(4):600-4. doi: 10.1002/ijc.20622. Int J Cancer. 2005. PMID: 15472908

5

Does the evidence matter in medicine? The retinoblastoma paradigm.

Mastrangelo D, De Francesco S, Di Leonardo A, Lentini L, Hadjistilianou T. Mastrangelo D, et al. Int J Cancer. 2007 Dec 1;121(11):2501-5. doi: 10.1002/ijc.22944. Int J Cancer. 2007. PMID: 17657745

6

The retinoblastoma paradigm revisited.

Mastrangelo D, De Francesco S, Di Leonardo A, Lentini L, Hadjistilianou T. Mastrangelo D, et al. Med Sci Monit. 2008 Dec;14(12):RA231-40. Med Sci Monit. 2008. PMID: 19043380 Review.

7

Retinoblastoma and the genetic theory of cancer: an old paradigm trying to survive to the evidence.

Mastrangelo D, Hadjistilianou T, De Francesco S, Loré C. Mastrangelo D, et al. J Cancer Epidemiol. 2009;2009:301973. doi: 10.1155/2009/301973. Epub 2009 Oct 27. J Cancer Epidemiol. 2009. PMID: 20445799 Free PMC article.

8

Retinoblastoma epidemiology: does the evidence matter?

Mastrangelo D, De Francesco S, Di Leonardo A, Lentini L, Hadjistilianou T. Mastrangelo D, et al. Eur J Cancer. 2007 Jul;43(10):1596-603. doi: 10.1016/j.ejca.2007.04.019. Epub 2007 May 31. Eur J Cancer. 2007. PMID: 17543516 Free article. Review.

9

Brief report: conservative treatment in unilateral retinoblastoma: a preliminary report.

Hadjistilianou T, Mastrangelo D, De Francesco S, Mazzotta C. Hadjistilianou T, et al. Among authors: mastrangelo d. Med Pediatr Oncol. 2002 Jun;38(6):439-41. doi: 10.1002/mpo.1359. Med Pediatr Oncol. 2002. PMID: 11984807 No abstract available.

10

Missing evidences in cancer genetics: the retinoblastoma paradigm.

Mastrangelo D, Di Leonardo A, Lentini L, De Francesco S, Hadjistilianou T. Mastrangelo D, et al. Cell Oncol. 2008;30(6):509-10. doi: 10.3233/clo-2008-0454. Cell Oncol. 2008. PMID: 18936530 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters